Literature DB >> 23812385

Central endogenous angiotensin-(1-7) protects against aldosterone/NaCl-induced hypertension in female rats.

Baojian Xue1, Zhongming Zhang, Ralph F Johnson, Fang Guo, Meredith Hay, Alan Kim Johnson.   

Abstract

In comparison to male rodents, females are protected against angiotensin (ANG) II- and aldosterone (Aldo)-induced hypertension. However, the mechanisms underlying this protective effect are not well understood. ANG-(1-7) is formed from ANG II by angiotensin-converting enzyme 2 (ACE2) and has an antihypertensive effect in the central nervous system (CNS). The present study tested the hypothesis that central ANG-(1-7) plays an important protective role in attenuating the development of Aldo/NaCl-hypertension in female rats. Systemic infusion of Aldo into intact female rats with 1% NaCl as their sole drinking fluid resulted in a slight increase in blood pressure (BP). Intracerebroventricular (icv) infusion of A-779, an ANG-(1-7) receptor (Mas-R) antagonist, significantly augmented the pressor effects of Aldo/NaCl. In contrast, systemic Aldo/NaCl induced a significant increase in BP in ovariectomized (OVX) female rats, and central infusion of ANG-(1-7) significantly attenuated this Aldo/NaCl pressor effect. The inhibitory effect of ANG-(1-7) on the Aldo/NaCl pressor effect was abolished by concurrent infusion of A-779. RT-PCR analyses showed that there was a corresponding change in mRNA expression of several renin-angiotensin system components, estrogen receptors and an NADPH oxidase subunit in the lamina terminalis. Taken together these results suggest that female sex hormones regulate an antihypertensive axis of the brain renin-angiotensin system involving ACE2/ANG-(1-7)/Mas-R that plays an important counterregulatory role in protecting against the development of Aldo/NaCl-induced hypertension.

Entities:  

Keywords:  aldosterone; angiotensin-(1–7); blood pressure; central nervous system

Mesh:

Substances:

Year:  2013        PMID: 23812385      PMCID: PMC3761325          DOI: 10.1152/ajpheart.00193.2013

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  33 in total

Review 1.  The protective effects of estrogen on the cardiovascular system.

Authors:  M E Mendelsohn; R H Karas
Journal:  N Engl J Med       Date:  1999-06-10       Impact factor: 91.245

2.  Estrogen receptor-alpha mediates estrogen protection from angiotensin II-induced hypertension in conscious female mice.

Authors:  Baojian Xue; Jaya Pamidimukkala; Dennis B Lubahn; Meredith Hay
Journal:  Am J Physiol Heart Circ Physiol       Date:  2006-12-01       Impact factor: 4.733

Review 3.  Aldosterone as a cardiovascular risk hormone.

Authors:  Takanobu Yoshimoto; Yukio Hirata
Journal:  Endocr J       Date:  2007-04-03       Impact factor: 2.349

Review 4.  NADPH oxidases of the brain: distribution, regulation, and function.

Authors:  David W Infanger; Ram V Sharma; Robin L Davisson
Journal:  Antioxid Redox Signal       Date:  2006 Sep-Oct       Impact factor: 8.401

5.  Effect of gender on the progression of nondiabetic renal disease: a meta-analysis.

Authors:  Joel Neugarten; Anjali Acharya; Sharon R Silbiger
Journal:  J Am Soc Nephrol       Date:  2000-02       Impact factor: 10.121

6.  Estrogen receptor-β in the paraventricular nucleus and rostroventrolateral medulla plays an essential protective role in aldosterone/salt-induced hypertension in female rats.

Authors:  Baojian Xue; Zhongming Zhang; Terry G Beltz; Ralph F Johnson; Fang Guo; Meredith Hay; Alan Kim Johnson
Journal:  Hypertension       Date:  2013-04-22       Impact factor: 10.190

7.  Characterization of a new angiotensin antagonist selective for angiotensin-(1-7): evidence that the actions of angiotensin-(1-7) are mediated by specific angiotensin receptors.

Authors:  R A Santos; M J Campagnole-Santos; N C Baracho; M A Fontes; L C Silva; L A Neves; D R Oliveira; S M Caligiorne; A R Rodrigues; C Gropen Júnior
Journal:  Brain Res Bull       Date:  1994       Impact factor: 4.077

Review 8.  Sex differences in angiotensin II- induced hypertension.

Authors:  B Xue; A K Johnson; M Hay
Journal:  Braz J Med Biol Res       Date:  2007-05       Impact factor: 2.590

9.  Female protection in progressive renal disease is associated with estradiol attenuation of superoxide production.

Authors:  Hong Ji; Wei Zheng; Stefano Menini; Carlo Pesce; James Kim; Xie Wu; Susan E Mulroney; Kathryn Sandberg
Journal:  Gend Med       Date:  2007-03

10.  Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation.

Authors:  Yumei Feng; Xinping Yue; Huijing Xia; Sharell M Bindom; Peter J Hickman; Catalin M Filipeanu; Guangyu Wu; Eric Lazartigues
Journal:  Circ Res       Date:  2008-02-07       Impact factor: 17.367

View more
  14 in total

1.  Age-related changes in thirst, salt appetite, and arterial blood pressure in response to aldosterone-dexamethasone combination in rats.

Authors:  Robert L Thunhorst; Baojian Xue; Terry G Beltz; Alan Kim Johnson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-04-01       Impact factor: 3.619

2.  Estrogen regulation of the brain renin-angiotensin system in protection against angiotensin II-induced sensitization of hypertension.

Authors:  Baojian Xue; Zhongming Zhang; Terry G Beltz; Fang Guo; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-05-23       Impact factor: 4.733

Review 3.  Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.

Authors:  Sadashiva S Karnik; Khuraijam Dhanachandra Singh; Kalyan Tirupula; Hamiyet Unal
Journal:  Br J Pharmacol       Date:  2017-03-09       Impact factor: 8.739

4.  Central ANG-(1-7) infusion improves blood pressure regulation in antenatal betamethasone-exposed sheep and reveals sex-dependent effects on oxidative stress.

Authors:  Alexa S Hendricks; Matthew J Lawson; Jorge P Figueroa; Mark C Chappell; Debra I Diz; Hossam A Shaltout
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-04-05       Impact factor: 4.733

Review 5.  ACE2 alterations in kidney disease.

Authors:  María José Soler; Jan Wysocki; Daniel Batlle
Journal:  Nephrol Dial Transplant       Date:  2013-08-16       Impact factor: 5.992

Review 6.  The ACE2/Angiotensin-(1-7)/MAS Axis of the Renin-Angiotensin System: Focus on Angiotensin-(1-7).

Authors:  Robson Augusto Souza Santos; Walkyria Oliveira Sampaio; Andreia C Alzamora; Daisy Motta-Santos; Natalia Alenina; Michael Bader; Maria Jose Campagnole-Santos
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

Review 7.  Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control.

Authors:  Annette D de Kloet; Meng Liu; Vermalí Rodríguez; Eric G Krause; Colin Sumners
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-06-17       Impact factor: 3.619

Review 8.  Angiotensin-(1-7) and Alamandine on Experimental Models of Hypertension and Atherosclerosis.

Authors:  Fernando Pedro de Souza-Neto; Melissa Carvalho Santuchi; Mario de Morais E Silva; Maria José Campagnole-Santos; Rafaela Fernandes da Silva
Journal:  Curr Hypertens Rep       Date:  2018-03-14       Impact factor: 5.369

Review 9.  Dimerization of AT2 and Mas Receptors in Control of Blood Pressure.

Authors:  Sanket Patel; Tahir Hussain
Journal:  Curr Hypertens Rep       Date:  2018-05-01       Impact factor: 5.369

Review 10.  Glycopeptide drugs: A pharmacological dimension between "Small Molecules" and "Biologics".

Authors:  Christopher R Apostol; Meredith Hay; Robin Polt
Journal:  Peptides       Date:  2020-07-13       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.